Stereospecific and competitive binding of drugs to human serum albumin: a difference circular dichroism approach.
Simultaneous binding of two drugs to human serum albumin (HSA) was investigated by difference circular dichroism (delta CD) spectroscopy. Phenylbutazone and diazepam were chosen as specific markers for binding areas I (cumarines) and II (indoles), respectively, and their stereospecific interactions with protein were selectively characterized. Displacers were drugs known to specifically bind to areas I (salicylate) and II (racemic ibuprofen). The results indicate two different interaction mechanisms: a direct competition one (diazepam-ibuprofen and phenylbutazone-salicylate) and an indirect competition one (diazepam-salicylate and phenylbutazone-ibuprofen). The two major binding areas on HSA are distinct, but not independent, entities. Finally, the dissociation constants of marker ligands and competitors complexed to HSA were determined by quantitative analysis of CD data.
Ascoli
G
G
Scuola Normale Superiore, Pisa, Italy.
Bertucci
C
C
Salvadori
P
P
D001667:Binding, Competitive; D002942:Circular Dichroism; D003975:Diazepam / Q000737:chemistry; D006801:Humans; D007052:Ibuprofen / Q000737:chemistry; D008024:Ligands; D010653:Phenylbutazone / Q000737:chemistry; D011485:Protein Binding; D012459:Salicylates / Q000737:chemistry; D012709:Serum Albumin / Q000737:chemistry*; D013237:Stereoisomerism
D008024:Ligands; D012459:Salicylates; D012709:Serum Albumin; D010653:Phenylbutazone; D003975:Diazepam; D007052:Ibuprofen